1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Zoonotic Disease Treatment Market, by Disease Type
6.1. Introduction
6.2. Rabies
6.3. Tuberculosis
6.4. Viral Hepatitis

7. Zoonotic Disease Treatment Market, by Drug Class
7.1. Introduction
7.2. Antibacterial Medication
7.3. Antibiotics

8. California Zoonotic Disease Treatment Market

9. Florida Zoonotic Disease Treatment Market

10. Illinois Zoonotic Disease Treatment Market

11. New York Zoonotic Disease Treatment Market

12. Ohio Zoonotic Disease Treatment Market

13. Pennsylvania Zoonotic Disease Treatment Market

14. Texas Zoonotic Disease Treatment Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. AstraZeneca PLC
16.2. Bavarian Nordic A/S
16.3. BIO-MED
16.4. Cadila Healthcare Limited
16.5. CSC Pharmaceuticals International
16.6. CSL Limited
16.7. CureVac AG
16.8. Dr. Reddy's Laboratories Ltd
16.9. F. Hoffmann-La Roche AG
16.10. GlaxoSmithKline PLC
16.11. Grifols, S.A
16.12. Informa PLC
16.13. Johnson & Johnson services, Inc
16.14. Kamada Ltd.
16.15. Kedrion Biopharma Inc
16.16. Merck & Co., Inc
16.17. Mylan N.V
16.18. Novartis International AG
16.19. Pfizer Inc.
16.20. Sanofi S.A
16.21. Solvay S.A.
16.22. Synermore Biologics Co., Ltd.
16.23. Taj Pharmaceuticals Limited
16.24. VBI Vaccines

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 6. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 15. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 20. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 21. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY RABIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY TUBERCULOSIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY VIRAL HEPATITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBACTERIAL MEDICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: SCORES
TABLE 11. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: BUSINESS STRATEGY
TABLE 12. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 13. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: RANKING
TABLE 14. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 15. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: MERGER & ACQUISITION
TABLE 16. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 17. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 18. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 19. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 20. UNITED STATES ZOONOTIC DISEASE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

AstraZeneca PLC
Bavarian Nordic A/S
BIO-MED
Cadila Healthcare Limited
CSC Pharmaceuticals International
CSL Limited
CureVac AG
Dr. Reddy's Laboratories Ltd
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Grifols, S.A
Informa PLC
Johnson & Johnson services, Inc
Kamada Ltd.
Kedrion Biopharma Inc
Merck & Co., Inc
Mylan N.V
Novartis International AG
Pfizer Inc.
Sanofi S.A
Solvay S.A.
Synermore Biologics Co., Ltd.
Taj Pharmaceuticals Limited
VBI Vaccines